FDA Import Refusal SCS-9268154-8/10002/1 — IBEBU
The FDA refused shipment SCS-9268154-8/10002/1 from IBEBU (South Korea) on Mar 11, 2026. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charges: 118,3280 This firm has 2 other import refusals on record.
Refusal details
- Date
- Mar 11, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 118,3280